{
    "2018-06-11": [
        [
            {
                "time": "2023-03-15",
                "original_text": "Inhibitors' Prospects Strong: 4 Stocks Ruling the Space",
                "features": {
                    "keywords": [
                        "JAK Inhibitors",
                        "Prospects",
                        "Strong",
                        "Stocks"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Abbvie/Roche's Leukemia Drugs Combination Gets FDA Approval",
                "features": {
                    "keywords": [
                        "Abbvie",
                        "Roche",
                        "Leukemia",
                        "Drugs",
                        "FDA",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AbbVie",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Bristol Myers",
                        "Merck",
                        "Roche",
                        "Lilly",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Abbvie/Roche's Leukemia Drugs Combination Gets FDA Approval",
                "features": {
                    "keywords": [
                        "Abbvie",
                        "Roche",
                        "Leukemia",
                        "Drugs",
                        "FDA",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space",
                "features": {
                    "keywords": [
                        "JAK Inhibitors",
                        "Prospects",
                        "Strong",
                        "Stocks"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}